← Open Payments lookup

DAVID TANIS: Open Payments

NPI 1598372807 · ANTHEM, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,830 in 114 payments from 15 companies in 2025. Trend: 2023 $1,787 · 2024 $2,748 · 2025 $1,830

Food & beverage: $1,830
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.30$405
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)19$305
ABBVIE INC.18$266
Alkermes, Inc.9$173
Lundbeck LLC8$137
Corium, LLC6$90
Axsome Therapeutics, Inc.4$84
Supernus Pharmaceuticals, Inc.5$83
Otsuka America Pharmaceutical, Inc.4$72
E.R. Squibb & Sons, L.L.C.3$57

Products named: INGREZZA, CAPLYTA, VRAYLAR, REXULTI, ARISTADA, Azstarys, Auvelity, Qelbree.

Industry payments across AZ — which companies pay providers there.